A Food and Drug Administration advisory committee is set to meet on December 10 to discuss Pfizer Inc.’s request for an emergency use authorization for its developing COVID-19 vaccine.
Pfizer and its German partner BioNTech recently announced that the vaccine appears 95 percent effective at preventing mild to severe COVID-19 disease in a large, ongoing study.
Dr. Moncef Slaoui, head of the Operation Warp Speed, the coronavirus vaccine program, says plans are to ship vaccines to states within 24 hours of expected FDA approval.
Slaoui told CNN he expects vaccinations would begin on the second day after approval, December 12.
Coronavirus: Moderna to charge $25-$37 for COVID-19 vaccine, CEO saysModerna will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered, Chief Executive ... Coronavirus
G20 leaders pledge to fund fair distribution of coronavirus vaccines: Draft statementLeaders of the world's 20 biggest economies on Sunday will pledge to pay for a fair distribution of COVID-19 vaccines, drugs and tests around the ... Coronavirus
Russia's Putin in G20: Ready to provide our coronavirus vaccine to countries in needRussia is prepared to provide its own coronavirus vaccine, Sputnik V, to countries in need, President Vladimir Putin said on Saturday in his address ... Coronavirus